Advertisement
Canada markets open in 9 hours 2 minutes
  • S&P/TSX

    24,162.83
    +194.33 (+0.81%)
     
  • S&P 500

    5,751.07
    +51.13 (+0.90%)
     
  • DOW

    42,352.75
    +341.15 (+0.81%)
     
  • CAD/USD

    0.7365
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    74.20
    -0.18 (-0.24%)
     
  • Bitcoin CAD

    86,385.08
    +2,296.23 (+2.73%)
     
  • XRP CAD

    0.74
    +0.02 (+2.15%)
     
  • GOLD FUTURES

    2,667.40
    -0.40 (-0.01%)
     
  • RUSSELL 2000

    2,212.80
    +32.65 (+1.50%)
     
  • 10-Yr Bond

    3.9810
    +0.1310 (+3.40%)
     
  • NASDAQ futures

    20,218.25
    -9.00 (-0.04%)
     
  • VOLATILITY

    19.21
    -20.49 (-51.61%)
     
  • FTSE

    8,280.63
    -1.89 (-0.02%)
     
  • NIKKEI 225

    39,481.69
    +846.07 (+2.19%)
     
  • CAD/EUR

    0.6709
    0.0000 (0.00%)
     

Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports

FILE PHOTO: Novo Nordisk hopes to launch experimental obesity drug this decade

(Reuters) - Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the scope of U.S. government price controls, the Financial Times reported on Monday.

(Reporting by Disha Mishra in Bengaluru; Editing by Christopher Cushing)